Milestone Pharmaceuticals Inc. Income Statement

Income Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 15.00M
Gross Profit 15.00M
Operating items
Research & Development 34.49M38.67M
Selling, General & Administrative 10.29M12.40M
Operating Expenses 44.77M51.07M
Operating Income -50.71M-43.07M
EBIT -50.71M-43.07M
Non-operating items
Interest & Investment Income 0.73M0.22M
Net income details
EBT -49.98M-42.85M
Tax Provisions -0.02M
Profit After Tax -49.97M-42.85M
Income from Continuing Operations -49.97M-42.85M
Consolidated Net Income -49.97M-42.85M
Income towards Parent Company -49.97M-42.85M
Net Income towards Common Stockholders -49.97M-42.85M
Additional items
EPS (Basic) -0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M
Shares Outstanding (Weighted Average) 23.15M24.49M29.85M29.87M34.29M33.48M53.33M
EBITDA -50.71M-43.07M
Tax Rate 0.03%